Tokyo Tape
Sign in
← Taiko Pharmaceutical

Half-year report · Q2

4574.TEDINET S100U6M9
Period2024-01-01 → 2024-06-30
Filed2024-08-09
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥2.9bn2024-01-01 → 2024-06-30Cons.Net sales
Revenue¥6.1bn2023-01-01 → 2023-12-31Cons.Net sales (5-year summary)
Revenue¥2.5bn2023-01-01 → 2023-06-30Cons.Net sales
Operating income¥482m2024-01-01 → 2024-06-30Cons.Operating income
Operating income−¥396m2023-01-01 → 2023-06-30Cons.Operating income
Ordinary income¥528m2024-01-01 → 2024-06-30Cons.Ordinary income
Ordinary income−¥1.2bn2023-01-01 → 2023-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥510m2023-01-01 → 2023-06-30Cons.Ordinary income
Profit before tax¥724m2024-01-01 → 2024-06-30Cons.Income before income taxes
Profit before tax−¥492m2023-01-01 → 2023-06-30Cons.Income before income taxes
Net income (owners)¥764m2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥3.6bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥514m2023-01-01 → 2023-06-30Cons.Profit loss attributable to owners of parent
Net income¥764m2024-01-01 → 2024-06-30Cons.Profit loss
Net income−¥514m2023-01-01 → 2023-06-30Cons.Profit loss
Total assets¥13.4bnat 2024-06-30Cons.Assets
Total assets¥13.2bnat 2023-12-31Cons.Assets
Total assets¥15.6bnat 2023-06-30Cons.Total assets (5-year summary)
Total liabilities¥5.3bnat 2024-06-30Cons.Liabilities
Total liabilities¥6.5bnat 2023-12-31Cons.Liabilities
Net assets / equity¥8.1bnat 2024-06-30Cons.Net assets
Net assets / equity¥6.7bnat 2023-12-31Cons.Net assets
Net assets / equity¥9.2bnat 2023-06-30Cons.Net assets (5-year summary)
Cash and deposits¥5.2bnat 2024-06-30Cons.Cash and deposits
Cash and deposits¥5.5bnat 2023-12-31Cons.Cash and deposits
Cash & equivalents¥4.9bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥5.2bnat 2023-12-31Cons.Cash and cash equivalents
Cash & equivalents¥4.5bnat 2023-06-30Cons.Cash and cash equivalents
Cash & equivalents¥2.8bnat 2022-12-31dCons.Cash and cash equivalents
Operating cash flow¥256m2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥307m2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥126m2023-01-01 → 2023-06-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥135m2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Investing cash flow¥1.2bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥707m2023-01-01 → 2023-06-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥562m2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥1.5bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥827m2023-01-01 → 2023-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥15.242024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-76.252023-01-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-11.362023-01-01 → 2023-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio60.3%at 2024-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio51.0%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio58.7%at 2023-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 26
SegmentItemPeriodValue
Otherother segmentsrevenue2024-01-01 → 2024-06-30¥2m
Otherother segmentsrevenue external2024-01-01 → 2024-06-30¥2m
Otherother segmentssegment profit2024-01-01 → 2024-06-30−¥6m
Reconciling Itemsreconcilingsegment profit2024-01-01 → 2024-06-30−¥401m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥203m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥203m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentsegment profit2024-01-01 → 2024-06-30−¥195m
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue2024-01-01 → 2024-06-30¥2.7bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue external2024-01-01 → 2024-06-30¥2.7bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentsegment profit2024-01-01 → 2024-06-30¥1.1bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-01-01 → 2024-06-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-01-01 → 2024-06-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-01-01 → 2024-06-30¥884m
Otherother segmentsrevenue2023-01-01 → 2023-06-30¥2m
Otherother segmentsrevenue external2023-01-01 → 2023-06-30¥2m
Otherother segmentssegment profit2023-01-01 → 2023-06-30−¥11m
Reconciling Itemsreconcilingsegment profit2023-01-01 → 2023-06-30−¥492m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥370m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥370m
jpcrp040300-q2r_E22560-000Infection Control Businessreportable segmentsegment profit2023-01-01 → 2023-06-30−¥407m
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-06-30¥2.1bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-06-30¥2.1bn
jpcrp040300-q2r_E22560-000Pharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-06-30¥514m
Total Of Reportable Segments And Otherssegment totalrevenue2023-01-01 → 2023-06-30¥2.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-01-01 → 2023-06-30¥2.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-01-01 → 2023-06-30¥95m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 518
ItemContextValueUnit
Current assetsPrior1YearInstant9109000000JPY
Current assetsCurrentQuarterInstant8795000000JPY
Buildings and structures netPrior1YearInstant1025000000JPY
Buildings and structures netCurrentQuarterInstant983000000JPY
Machinery equipment and vehicles netPrior1YearInstant826000000JPY
Machinery equipment and vehicles netCurrentQuarterInstant758000000JPY
LandPrior1YearInstant1675000000JPY
LandCurrentQuarterInstant1675000000JPY
Construction in progressPrior1YearInstant2000000JPY
Construction in progressCurrentQuarterInstant22000000JPY
Other net ppePrior1YearInstant50000000JPY
Other net ppeCurrentQuarterInstant53000000JPY
Property plant and equipmentPrior1YearInstant3581000000JPY
Property plant and equipmentCurrentQuarterInstant3494000000JPY
Intangible assetsPrior1YearInstant1000000JPY
Intangible assetsCurrentQuarterInstant24000000JPY
Investment securitiesPrior1YearInstant236000000JPY
Investment securitiesCurrentQuarterInstant781000000JPY
Other ioaPrior1YearInstant291000000JPY
Other ioaCurrentQuarterInstant286000000JPY
Investments and other assetsPrior1YearInstant527000000JPY
Investments and other assetsCurrentQuarterInstant1068000000JPY
Noncurrent assetsPrior1YearInstant4111000000JPY
Noncurrent assetsCurrentQuarterInstant4587000000JPY
AssetsPrior1YearInstant13220000000JPY
AssetsCurrentQuarterInstant13383000000JPY
Notes and accounts payable tradePrior1YearInstant375000000JPY
Notes and accounts payable tradeCurrentQuarterInstant380000000JPY
Current portion of long term loans payablePrior1YearInstant1206000000JPY
Current portion of long term loans payableCurrentQuarterInstant1276000000JPY
Accounts payable otherPrior1YearInstant740000000JPY
Accounts payable otherCurrentQuarterInstant334000000JPY
Income taxes payablePrior1YearInstant42000000JPY
Income taxes payableCurrentQuarterInstant39000000JPY
Refund liabilities clPrior1YearInstant72000000JPY
Refund liabilities clCurrentQuarterInstant63000000JPY
Provision for bonusesPrior1YearInstant75000000JPY
Provision for bonusesCurrentQuarterInstant48000000JPY
Provision for loss on subleases clPrior1YearInstant48000000JPY
Provision for loss on subleases clCurrentQuarterInstant11000000JPY
Asset retirement obligations clPrior1YearInstant203000000JPY
Asset retirement obligations clCurrentQuarterInstant17000000JPY
Other clPrior1YearInstant281000000JPY
Other clCurrentQuarterInstant264000000JPY
Current liabilitiesPrior1YearInstant3046000000JPY
Current liabilitiesCurrentQuarterInstant2437000000JPY
Long term loans payablePrior1YearInstant1999000000JPY
Long term loans payableCurrentQuarterInstant1326000000JPY
Long term accounts payable otherPrior1YearInstant549000000JPY
Long term accounts payable otherCurrentQuarterInstant549000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net assetsconsolidated 2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2023-01-01/2023-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-06-30pass